Alefacept in the treatment of psoriatic nail disease: a proof of concept study

Parrish, C.A.; Sobera, J.O.; Robbins, C.M.; Cantrell, W.C.; Desmond, R.A.; Elewski, B.E.

Journal of Drugs in Dermatology Jdd 5(4): 339-340

2006


ISSN/ISBN: 1545-9616
PMID: 16673801
Document Number: 8226
Nail psoriasis can be debilitating and as therapeutic options are limited, it can be notoriously difficult to treat. As there are many new medications currently undergoing clinical trials in psoriasis, questions have arisen concerning the effectiveness of these new therapies with regard to psoriatic nail disease. We present the results of a prospective, open-label, proof of concept study to determine the efficacy and safety of alefacept in subjects with moderate to severe nail psoriasis.

Document emailed within 1 workday
Secure & encrypted payments

Alefacept in the treatment of psoriatic nail disease: a proof of concept study